1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Comparison between the series from Le Roux et al and our series after including patients who had moderate disability

HH Scale GradeLe Roux et al2,3Natarajan et al1
Favorable Outcomes (good-to-moderate disability, GOS 4 and 5) at 6 months (%)Favorable Outcomes (good-to-mild disability, mRS 0–2) at 3 months (%)Favorable Outcomes (good-to-moderate disability, including mRS 0–3) at 3 months (%)
I978693
II888589
III815780
IV546080
V243549
  • Note:—HH indicates Hunt and Hess; GOS, Glasgow Outcome Score; mRS, modified Rankin Scale.